Transitional cell carcinoma is the most common cancer of the canine urinary tract. The inconsistent appearance of transitional cell carcinoma in patients introduces error if applying mathematic models for extrapolating total tumor volume from linear measurements. Reliable techniques to assess tumor size are important for monitoring treatment response. A method comparison study was performed comparing four techniques for calculating tumor volume were compared:
INTRODUCTION
Transitional cell carcinoma is the most common cancer of the canine urinary tract. 1 The prevalence of naturally occurring transitional cell carcinoma in dogs is not fully understood, but it is estimated to be approximately 1-2% of all canine cancers. 2 Urinary bladder transitional cell carcinomas have different sizes, shapes, and distributions in dogs. These characteristics may change in an individual dog throughout the course of the disease particularly in response to treatment. Treatment for dogs with nonsurgical transitional cell carcinoma most commonly consists of a combination of nonsteroidal anti-inflammatory drugs, chemopharamceuticals, small molecular inhibitors, and/or radiation therapy. These therapies are aimed at reducing the tumor volume to palliate clinical signs, thus improving quality of life. Surgical intervention is often difficult because the disease is frequently in a trigonal location and may have a multifocal distribution. 3 Mapping of the bladder to characterize the location of the transitional cell carcinoma tumor is poignant in the clinical evaluation and staging for disease to determine if surgery is an option. 4 Even when surgical excision is possible, the goal of surgery may be limited to diagnostic purposes or for palliation of clinical signs due to the inability to obtain appropriate surgical margins and the effect of field carcinogenesis on the remaining urinary bladder tissue. 4, 5 Vet Radiol Ultrasound. 2018;59:767-776.
c 2018 American College of Veterinary Radiology 767 wileyonlinelibrary.com/journal/vru Response Evaluation Criteria in Solid Tumors guidelines provide established objective measures to dictate and categorize effectiveness of chemotherapy drugs. 6 The Response Evaluation Criteria in Solid Tumors guidelines are important for testing efficacy of novel therapeutics in clinical trials and the response of an individual patient to treatment. The Response Evaluation Criteria in Solid Tumors guidelines use linear measurements in the longest dimension of the tumor and percentage changes in this length to monitor response to treatment or progression of disease: progressive disease is an increase of 20%, partial response is a decrease of 30%, and stable disease is an increase of less than 20% and/or decrease of less than 30%.
A complete response is considered to be the absence of tumor at the recheck. Ultrasound is commonly used for tumor monitoring and measurement in veterinary medicine. However, ultrasound in considered an inappropriate tool in human medicine due to the high user dependency and low interobserver reliability. 6 Previous veterinary studies demonstrated that intraobserver repeatability of ultrasoundbased linear tumor measurements can be excellent, but interobserver measurements had a significantly high variation. 5 Intraobserver twodimensional ultrasonographic measurements of transitional cell carcinoma tumors in dogs vary based on the degree of bladder distension with a poor agreement when interobserver reliability is compared between ultrasonographers. 7 There is evidence that a single highly experienced user guided by a specific approach to urinary bladder tumors can have a high repeatability for linear measurements; however, the interobserver reliability within this study was poor. 8 The same study also found that CT volume measurements were more reliable than ultrasound, as well as, more consistent for tumor measurements at varying volumes of urinary bladder distention. 8 In people, cross-sectional modalities like magnetic resonance imaging (MRI) and CT are used for assessing the treatment response of solid tumors. 9 There have been multiple clinical trials performed in a variety of different tumor types utilizing the Response Evaluation Criteria in Solid Tumors guidelines to evaluate chemotherapy and radiation therapy protocols. 4, 5, [10] [11] [12] [13] [14] [15] However, the inconsistent, irregularly shaped uri- It is hypothesized that volumes based on linear measurements made using CT and ultrasound will yield significantly different volumes than CT tracing volumes for urinary bladder transitional cell carcinoma.
It is also hypothesized that the linear measurements will result in significantly greater calculated tumor volumes when compared to volumes calculated from tracing the margins of the tumors on CT images.
METHODS
This clinical trial was approved by the Clinical Research and Advising Committee at the College of Veterinary Medicine and Institutional Animal Care and Use Committee at Ohio State University. Images were collected from 10 dogs that were concurrently enrolled in a parent study evaluating the combination of toceranib and vinblastine for canine transitional cell carcinoma. A priori power analysis was used to compute the sample size of paired measurements to detect a significant difference in the tumor volume between techniques (G*Power, v.3.1.9.2., http://www.gpower.hhu.de/en.html). The data used for the power analysis were sampled from a subset of the dogs with urinary bladder transitional cell carcinoma. The volumes were generated from linear ultrasound measurements and tracing volumes on CT postcontrast with a two-tailed matched-pair analysis to calculate a correlation of 0.6789327 between techniques. From this analysis, 22 match paired measurements provides sufficient power (1 -= 0.8) to identify a significant ( = 0.05) difference in a method comparison study. Cytologic confirmation of transitional cell carcinoma from either a urine cytospin or traumatic catheterization was required for study entry. 5 The imaging studies, ultrasound and CT, were performed before chemotherapeutic treatment (week 0), then at weeks 8 and 16 of the study.
The patients were under general anesthesia for all imaging studies and measurement acquisitions at week 0, 8, and 16. Some dogs were removed from the study before either the week 8 or week 16 rechecks due to criteria defined by the parent study. In total, 24 total tumors were measured. Five dogs were imaged at week 0, 8, and 16, four dogs were imaged at week 0 and 8, and one dog was imaged only at week 0.
Tumor measurements: Ultrasound
After placement of a Foley catheter (Bardex R Foley Catheter, C.R.
Bard, Inc, Covington, GA), the urinary bladder was emptied. Sterile 0.9% saline was instilled into the urinary bladder at a dose of 2 ml/kg.
The urinary catheter was withdrawn into the proximal urethra. All exams were performed with the patient in dorsal recumbency using a observer (E.M.G.) was the observer on the remaining three time points.
All observers had at least 16 years of veterinary ultrasound experience.
Tumor volumes were calculated using equation (1) and the maximum tumor dimension in three orthogonal planes (length, width, and height). 16 6 × (Length × Width × Height) .
This formula assumes the tumor has an ellipsoid shape. Each tumor volume was calculated twice using the measurements obtained by each observer at each evaluation and an average tumor volume was calculated using the mean value of the three measurements obtained by both observers at each evaluation.
Tumor measurements: Computed tomography
The Three separate series were acquired and were as follows: (1) 
Statistical analysis
Statistical analysis was performed by an epidemiologist (G.G.T.) using SAS v. 9.4 (Cary, North Carolina).
Overall differences in the calculated volumes made using the four techniques (CT-linear, CT-tracing precontrast, CT-tracing postcontrast, and ultrasound-linear) were tested using a mixed effects model (PROC MIXED, SAS, v. 9.4). To correct for the lack of independence between observations, dog was included as a random intercept, and the variables for week of observation and observer (A or B) were included as fixed effects. The differences in calculated volumes made using the four techniques were tested by including technique as a fixed effect in the model. The calculated volumes made using each technique were log-transformed, and the derived values for the least-squared means and 95% confidence intervals were subsequently back-transformed. Significance was considered at an -value of 0.05.
The intraclass correlation coefficient was calculated using separate two-level random effects mixed models for each technique. Calculated volume was the dependent variable, and a random intercept was 
RESULTS
Ten dogs were enrolled in the parent study between 2011 and 2014.
The median age was 11.5 years (mean 11.5, range 9-14) with a median weight of 13.6 kg (mean 17.1, range 8.1-29.2). Eight dogs were spayed females and two were castrated males. There were five mixed breed dogs, two West Highland white terriers, one Shetland sheepdog, one Scottish terrier, and one greyhound. When the volumes calculated by the four methodologies were averaged between the observers, the linear methods were significantly larger when compared to the average tumor volume for each tumor.
TA B L E 1
The volumes generated by tracing tumor margins on CT were significantly smaller (Table 1 and Figure 3 ). Of the 24 total calculated tumor volumes, only four volumes calculated using ultrasound linear measurements and five volumes calculated using CT linear measurements were less than the average volume of the four methods (Figures 4 and   5 ). Four calculated tumor volumes using the tracing technique on CT images had a greater volume for both the precontrast and postcontrast CT series compared to the average volume of the four methods (Figures 4 and 5 ).
The intraclass correlation was calculated for reliability between the observers ( Table 2 ). The highest intraclass correlation coefficient (0.868, moderate correlation) was found when comparing volumes calculated based on tracing the tumor margins on the precontrast CT series. The lowest intraclass correlation coefficient (0.611, poor correlation) was found when comparing volumes calculated using linear measurements on ultrasound.
A total of 14 tumors at unique time points in the nine dogs were evaluated for response to therapy using the Response Evaluation
Criteria in Solid Tumors guidelines as part of the parent study (Table 3) .
This study applied the unidimensional Response Evaluation Criteria in
Solid Tumors guidelines to the volumes calculated from the CT tracing and three linear dimensional measurement-based methods in order to demonstrate how the Response Evaluation Criteria in Solid Tumors status may differ from the current unidimensional based method (Table 3) . No cases were considered complete response in this study.
Only one tumor had agreement between the two unidimensional methods, two methods using the three linear dimensions for volume, and two tracing volumetric methods; this tumor was defined as stable 
DISCUSSION
The tumor volumes calculated using the CT tracing methodology were significantly smaller than volumes calculated using CT and ultrasound Once the longest diameter of a solid tumor is established, the same
TA B L E 3 Response Evaluation Criteria in Solid Tumors categorization of the tumors at rechecks. Response Evaluation Criteria in Solid Tumors was applied to tumor volumes to compare the unidimensional linear methods. A total of nine tumors at 14 time points were available for rechecks

Volumetric analysis Unidimensional
Pretrace CT Posttrace CT Linear CT Linear ultrasound CT Ultrasound however, there are no relatively straightforward mathematic models that embody the wide array of tumor shapes for transitional cell carcinoma. 16 The calculated volumes based on the three linear dimensions were significantly different, and larger, than those volumes calculated by tracing the tumor margins on serial images (Figures 4, and 5 ).
Greater changes in tumor size are required to identify tumor response to therapy when linear measurement-based volume calculations are used vs. more accurate methods of volume calculation. 19 The tracing method is able to identify smaller volumetric tumor changes because of its contoured nature, potentially improving sensitivity and accuracy for the assessment of tumor response to therapy. 19 Utilizing a unidimensional or other linear measuring scheme may falsely designate a tumor as stable or progressive, potentially overlooking efficacious therapeutic agents, as these methods typically overestimate tumor volume. In our study, 11 dogs had stable disease using linear ultrasound methods and 10 dogs had stable disease using linear CT methods, while volume calculation identified four dogs designated as stable disease using tracing methods on pre-and postcontrast CT and six dogs had stable disease using three linear dimensional measuring methods.
The linear measurement and tracing-based volume calculation methodologies used in this study resulted in differing tumor volumes.
Overestimating tumor size using linear measurement-based calculations can impact assessment of response to therapy classification.
Inaccurate assessment of response can result in a therapy being discontinued early or continued despite not having the desired effect.
It is especially important that tumor measurements be accurate and One tumor of 14 (7.1%) was categorized as stable disease using all methods.
Volume calculations based on tumor tracings are more representative for the evaluation of response to therapeutics due to the This study is a retrospective analysis of a prospectively gathered data set. Though the retrospective nature is a limitation, the protocol was relatively standardized enabling evaluation of the different modalities. The gold standard for determining accuracy of the methods would be histopathologic measurements of transitional cell carcinoma masses for comparison; however, response to therapy was a goal of the parent study, thereby limiting gross measurements. Three-dimensional ultrasound has been used to evaluate tumor size with high reliability; three-dimensional ultrasound was not included in this project. 20 The costs comparing abdominal ultrasound and CT at our clinic do not differ enough to favor one modality; therefore, the limitation of cost difference between the two modalities will be dependent on the hospital. 
CONFLICT OF INTEREST
Toceranib was provided by Zoetis for this clinical trial.
ORCID
Eric T. Hostnik http://orcid.org/0000-0002-7651-4775
